Peptides DB
Research-centric peptide and protocol reference hub
Study 13 of 13AOD-9604 literatureDEN open · Observational2023

Evaluation of Computer-aided Detection for Identifying Missed Gastric Cancer After Endoscopic Submucosal Dissection.

CADe showed no significant improvement in sensitivity for detecting missed gastric cancers compared to endoscopists, and both methods had low sensitivity overall.

Read at DEN openAdd to compare

Where it sits

this study against the rest of the aod-9604 corpus
1
Preclinical
7
Observational · this one
1
Open-label
1
Randomised
3
Reviews

Summary and findings

The study evaluated the efficacy of computer-aided detection (CADe) for identifying missed gastric cancers (MGCs) after endoscopic submucosal dissection (ESD) using 2324 endoscopic images. The per-lesion sensitivity for CADe was 15.0% compared to 13.8% for endoscopist detection. The findings indicate no significant difference in sensitivity between the two methods.

How much of this paper we could read: full text read (0.80). We had a clear abstract, so the summary below closely tracks the paper. What this means →
Per-lesion sensitivity for MGCs was 15.0% (9/60) for CADe and 13.8% (83/600) for endoscopist detection, p = 0.538.n=23242023

Abstract

The authors’ words, as DEN open supplied them

<h4>Objectives</h4>Computer-aided detection (CADe) using deep learning is promising for reducing missed gastric cancers (MGCs) and supporting physicians in double-checking endoscopic images. We aimed to evaluate the CADe efficacy for MGCs after endoscopic submucosal dissection (ESD).<h4>Methods</h4>We collected 2324 endoscopic images, including 60 of MGCs detected during surveillance esophagogastroduodenoscopy within 18 months after initial ESD. The performance of the CADe system, developed for early GC detection using deep learning, was compared with that of 10 endoscopists in a detection study using collected images. Per-lesion sensitivity, per-image detection performance, and diagnostic time were compared.<h4>Results</h4>The per-lesion sensitivity for MGCs was 15.0% (9/60) and 13.8% (83/600) for CADe and endoscopist detection, respectively (<i>p</i> = 0.538). The respective per-image computer-aided and endoscopist performance sensitivity was 11.3% and 10.6% (<i>p</i> = 0.548), specificity 88.5% and 94.8% (<i>p</i> < 0.001), positive predictive value 4.4% and 8.3%, and negative predictive value 95.7% and 96.0%. The per-image CADe time was significantly shorter (0.03 s vs. 2.86 s, <i>p</i> < 0.001). CADe showed higher sensitivity in certain subgroups, although these findings should be interpreted cautiously given the small sample size.<h4>Conclusions</h4>No significant difference in sensitivity was observed between CADe and endoscopist detection for MGCs after ESD, and the absolute sensitivity remained low. Further improvements are needed before clinical implementation of CADe as a double-checking tool.<h4>Trial registration</h4>The authors have confirmed clinical trial registration is not needed for this submission.

Background

This paper addresses the challenge of missed gastric cancers (MGCs) after endoscopic submucosal dissection (ESD), a significant concern in gastroenterology. Prior studies have indicated that computer-aided detection (CADe) using deep learning may assist in identifying MGCs, but its efficacy compared to human endoscopists was not well established. This study is important as it evaluates the performance of CADe in a real-world setting, potentially influencing future diagnostic practices.

Methods

The study collected 2324 endoscopic images, including 60 MGCs detected during surveillance esophagogastroduodenoscopy within 18 months post-ESD. The performance of the CADe system was compared with that of 10 endoscopists in a detection study. Primary outcome measures included per-lesion sensitivity, per-image detection performance, and diagnostic time.

Results

The per-lesion sensitivity for MGCs was 15.0% (9/60) for CADe and 13.8% (83/600) for endoscopist detection, with a p-value of 0.538. The per-image sensitivity was 11.3% for CADe and 10.6% for endoscopist, p = 0.548. Specificity was 88.5% for CADe and 94.8% for endoscopist, p < 0.001. The positive predictive value was 4.4% for CADe and 8.3% for endoscopist, while the negative predictive value was 95.7% for CADe and 96.0% for endoscopist. The diagnostic time for CADe was significantly shorter at 0.03 seconds compared to 2.86 seconds for endoscopist detection, p < 0.001.

Interpretation

The study found no significant difference in sensitivity between CADe and endoscopist detection for MGCs, suggesting that while CADe may offer time efficiency, its clinical utility remains limited due to low sensitivity. The findings align with previous literature indicating that while CADe can assist in detection, it does not replace the need for skilled endoscopists. The small sample size and low absolute sensitivity are confounding factors that limit the conclusions drawn from this study.

Key findings

  • Per-lesion sensitivity for MGCs was 15.0% (9/60) for CADe and 13.8% (83/600) for endoscopist detection, p = 0.538.
  • Per-image sensitivity for CADe was 11.3% and for endoscopist was 10.6%, p = 0.548.
  • Specificity for CADe was 88.5% and for endoscopist was 94.8%, p < 0.001.
  • Positive predictive value was 4.4% for CADe and 8.3% for endoscopist.
  • Negative predictive value was 95.7% for CADe and 96.0% for endoscopist.
  • CADe time was significantly shorter at 0.03 s compared to 2.86 s for endoscopist detection, p < 0.001.

Limitations

  • small sample size of 60 MGCs
  • absolute sensitivity remained low
  • no significant difference in sensitivity between CADe and endoscopist
  • further improvements needed before clinical implementation

Elsewhere in the AOD-9604 corpus

BTranspapillary Placement of a Multihole Covered Metal Stent Using a 5.9-Fr Delivery System Through a Forward-viewing Endoscope in Malignant Biliary Obstruction With Type I Duodenal Stenosis.DEN open · 2026 · n=1 · Not reported in abstract.HumanBPrediction of structural glaucoma progression from baseline fundus photographs using deep learning: a retrospective multicentre study.The Lancet. Digital health · 2026 · n=13913 · Maximum AUC of 0·98 (95% CI 0·97-1·00) in internal validation across follow-up intervals (2-5 years).HumanBBalloon Enteroscopy-assisted Endoscopic Retrograde Cholangiopancreatography for Choledocholithiasis in Situs Inversus Totalis With Billroth II Reconstruction: A Case Report and Literature Review.DEN open · 2023 · n=1 · Not reported in abstract.HumanBUnderestimation of Subserosal Invasion in Early Gastric Cancer-Like Advanced Gastric Carcinoma With Focal Enteroblastic Differentiation: A Case Report.DEN open · 2023 · n=1 · Subserosal invasion (pT3 [SS]) identified post-surgery.HumanAMetabolic and vascular outcomes after transition to the MiniMed 780G system in adults ≥65 years with type 1 diabetes: a randomised, single-centre study.Diabetologia · 2026 · Time in range increased from 57.4% at baseline to 79.7% at 12 months, p<0.001.HumanDAdvances in tuberculosis diagnostics and biomarkers, 2020-26: scientific evidence, recommendations, gaps, and developmental priorities.The Lancet. Microbe · 2026review